Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs
Summary of the Progress and Challenges in the Repurposing Kinase Inhibitors as Broad-Spectrum Antiviral Therapies
The Top 15 Best-Selling Drugs of 2017
Amid Talk of Curbing Prices, Most Treatments Show Sales Gains
Immuno-Oncology Enhances Battlespace Awareness
Molecular Imaging Could Help Clinicians Accurately Select Patients for Treatment or Monitoring
Crowdfunding for Science: Models of Best Practice
It’s Not Just the Science That Has to Be Memorable
For full access to this article login to GEN Select now.
Supplement: Integrated Continuous Manufacturing of Biologics
Biosimilar Manufacturers, Take Note: This Stream Is for You
- Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for drug makers looking to trim manufacturing budgets. But not all biologics would be feasible candidates for a truly integrated ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.